| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.2 |